Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Pubmed ID :29620223
Publication Date : //

Resveratrol decreases Rad51 expression and sensitizes cisplatin‑resistant MCF‑7 breast cancer cells.


Resveratrol (RES), a polyphenol compound with anti‑proliferative properties, has been previously evaluated for its beneficial effects against a variety of tumour cells. The current study elucidated the means by which RES enhances the anti‑proliferative effects of cisplatin (CIS) on MCF‑7 cells, focusing on the inhibitory effects on DNA repair of double‑strand breaks (DSBs). Chemoresistant MCF‑7 cells (MCF‑7R) were generated by continuous exposure to low concentrations of CIS (10 µM CIS‑IC40) during 5 passages, with the IC50 value increasing ~3‑fold. Using an MTT assay, we estimated the changes in IC50 for CIS in MCF‑7, T47‑D, MDA‑MB‑231 and MCF‑7R cells in the presence of RES. The relative transcript level of Nbs‑1, Mre‑11 and Rad‑50 genes was assessed using RT‑qPCR analysis. Rad51 and H2AX [pSer139] protein expression was determined by western blot analysis. RES at 50 and 100 µM significantly enhanced the anti‑proliferative effects of CIS in both MCF‑7 and MCF‑7R cells, decreasing the IC50 values for CIS to one‑tenth and one‑sixth, respectively. A total of 100 µM RES decreased the relative transcript levels of homologous recombination (HR) initiation complex components and the Rad51 protein level in MCF‑7 and MCF‑7R cells. After 48 h of CIS DNA damage, the levels of Rad51 protein increased, but this effect was inhibited by 100 µM RES. RES also maintained serine 139 phosphorylation of histone H2AX, suggesting that RES prevents the repair of DSBs. It was observed that RES exerts an antagonistic effect over CIS on the activation of Rad51 and sustained phosphorylation of H2AX. The results suggest that RES in combination with DNA damage‑based therapy has potential as a strategy to overcome resistance and provide much safer and more effective treatment for breast cancer.

Authors : Leon-Galicia I , Diaz-Chavez J , Albino-Sanchez M E , Garcia-Villa E , Bermudez-Cruz R , Garcia-Mena J , Herrera L A , García-Carrancá A , Gariglio P ,

Related products :

Catalog number Product name Quantity
Breast - BRC1502 Breast cancer array, non_overlapping with BRC1501, consists of duplicated 70 cases covering all the common types of breast cancer and 5 cases of normal and other non_malignant breast tissues. 1.1mm
Breast - BRC961 Breast cancer array consists of duplicated 36 cases covering all the common types of breast cancer and 12 cases of normal and other non_malignant breast tissues. 1.5mm
Breast - BRC1501 Breast cancer array consists of duplicated 70 cases covering all the common types of breast cancer and 5 cases of normal and other non_malignant breast tissues. 1.1mm
Breast - BRC481 Breast cancer array, 16 cases of breast cancer, each in duplicates, paired with corresponding uninvolved tissues from the same patients 2mm
Breast - BRC491 Breast cancer array, 49 cases of breast cancer, together with BRC711 forming the breast cancer array set. 1.7mm
Breast - BRC711 Breast cancer array, 71 cases of breast cancer, together with BRC491 forming the breast cancer array set. 1.1mm
orb60383 Resveratrol Resveratrol is a phytoalexin produced naturally by several plants with anti-cancer, anti-inflammatory, blood-sugar-lowering and other beneficial cardiovascular effects. For research use on 500 mg
30-121 C21orf33 inhibits both estrogen- and heregulin-beta1-stimulated growth of breast cancer cells, and further suggests that growth inhibition induced in these cells by all-trans retinoic acid occurs via 0.1 mg
BC08014 Breast cancer (multiple types of breast cancer) tissue array, 63 cases_63 cores, replaced by BR8018
BC08014 Breast cancer (multiple types of breast cancer) tissue array, 63 cases_63 cores, replaced by BR8018; ihc Anti-Actin confirmed
1240 Breast cancer, matched metastatic carcinoma and cancer adjacent normal breast tissue array, including TNM, clinical stage and pathology grade, 48 cases_ 96 cores,
9-47027 Human Cancer PrimaCell™4: Breast Tumor Cells, primary cell culture set
9-80027 Human Cancer PrimaCell™4: Breast Tumor Cells, primary cell culture 1 x 100 ml
2-96027 Human Cancer PrimaCell™4: Breast Tumor Cells, primary cell culture Kit
9-46027 Human Cancer PrimaCell™4: Breast Tumor Cells, primary cell culture 5 x 100 ml
4-28027 Human Cancer PrimaCell™4: Breast Tumor Cells, primary cell culture Kit
28-036 PCGF4 regulates telomerase expression in MECs and plays a role in the development of human breast cancer. 0.05 mg
PR-763 BRCA1His Breast per Ovary Cancer Gene 1 Product, Tumor Suppressor Protein and Transcription Factor human, recombinant, Sf9 insect cells 2
AP-305-U Breast Cancer Cells (a-peptide 18), Peptide Aptamer, Unlabelled Species Reactivity: 5 mg Product tipe: Peptide Aptamers
AP-305-B Breast Cancer Cells (a-peptide 18), Peptide Aptamer, Biotinylated Species Reactivity: 1 mg Product tipe: Peptide Aptamers
AP-305-F Breast Cancer Cells (a-peptide 18), Peptide Aptamer, FITC labelled 1 mg
AP-305-F Breast Cancer Cells (a-peptide 18), Peptide Aptamer, FITC labelled Species Reactivity: 1 mg Product tipe: Peptide Aptamers
AP-305-B Breast Cancer Cells (a-peptide 18), Peptide Aptamer, Biotinylated 1 mg
AP-305-U Breast Cancer Cells (a-peptide 18), Peptide Aptamer, Unlabelled 5 mg
Breast - BRC962 Without overlapping with the cancer cases in BRC961, BRC962 contains further 36 cases in duplicates covering all the common types of breast cancer and 12 cases of normal and other non_malignant breas 1.5mm


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur